drugset / Trial / NCT00289367

Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT00289367

RandomizedSingle-groupQuadruple-blindPrevention

Summary

The purpose of this project is to see whether treatment with a thyroid hormone, called triiodothyronine or T3, following open heart surgery reduces the risk of developing atrial fibrillation.

Timeline

Start
2006-02
Primary completion
2006-08
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Liothyronine Small molecule 0.8 ug/kg Intravenous

Indications